Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 8/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HTR4 | Q13639 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31486789 | 0.87 | HTR3A (0.54) | HTR3AGAAALDH1A1ALOX15 | |
| SCHEMBL31487099 | 0.85 | HTR4 (0.47) | HTR3AGAAALDH1A1KDM4EHTR4 | |
| SCHEMBL31486775 | 0.85 | USP2 (0.48) | HTR3AGAAMAPK1 | |
| Formic Acid SCHEMBL31487201 | 0.84 | HTR3A (0.51) | HTR3AGAAALDH1A1ALOX15 | |
| Formic Acid SCHEMBL31486974 | 0.82 | HTR4 (0.44) | HTR3AGAAALDH1A1KDM4EHTR4 | |
| Formic Acid SCHEMBL31486808 | 0.82 | HTR3A (0.54) | HTR3A | |
| Formic Acid SCHEMBL31486902 | 0.82 | HTR3A (0.54) | HTR3A | |
| SCHEMBL31486779 | 0.81 | HTR3A (0.54) | HTR3A | |
| SCHEMBL31487330 | 0.74 | KMT2A (0.57) | GAAMAPK1ALDH1A1KDM4EKMT2A | |
| SCHEMBL31486817 | 0.74 | KMT2A (0.57) | GAAMAPK1ALDH1A1KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025077825-A1 | METHODS AND COMPOSITIONS FOR TREATING CARDIO-PULMONARY DISORDERS | FAUNA BIO INCORPORATED (US) | 2025-04-17 | — | — | WO | disclosed |